Data Foundry

Drug recalls 2018

Oxycodone Hydrochloride Tablets — Class III drug recall D-0248-2018

Terminated recall by Ascent Pharmaceuticals, Inc., reported 2018-02-07, distributed nationwide. Labeling; Label Error Not Elsewhere Classified; label missing controlled substance CII symbol

Recall numberD-0248-2018
Product typeDrug
ClassificationClass III
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmAscent Pharmaceuticals, Inc., Central Islip, NY, United States
Recall initiated2018-01-22
Classified2018-02-01
Reported by FDA2018-02-07
Terminated2018-04-23
DistributedNationwide (US)
Quantity45,875 bottles
Reason classeslabeling
NDC31722-0484, 31722-0484-01, 31722-0484-05, 31722-0485, 31722-0485-01, 31722-0485-05, 31722-0486, 31722-0486-01, 31722-0486-05, 31722-0917, 31722-0917-01, 31722-0917-05, 31722-0918, 31722-0918-01, 31722-0918-05
Lot numbers07/19, 10/19, 11/19, 17080591, 17080619, 17110907, 17110908, 17120986

Product

Oxycodone Hydrochloride Tablets, USP 15 mg, 100 count bottles, Rx only, Manufactured for Camber Pharmaceuticals, Inc., Piscataway, NJ, Manufactured by: Ascent Pharmaceuticals, Inc., Central Islip, NY --- NDC 31722-917-01

Reason for recall

Labeling; Label Error Not Elsewhere Classified; label missing controlled substance CII symbol

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0248-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.